Urban-rural-specific trend in prevalence of general and central obesity, and association with hypertension in Chinese adults, aged 18-65 years.


Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
30 May 2019
Historique:
received: 27 06 2018
accepted: 21 05 2019
entrez: 1 6 2019
pubmed: 31 5 2019
medline: 25 7 2019
Statut: epublish

Résumé

China has the largest obese population in the world, and the prevalence of central obesity is increasing dramatically in China. Moreover, the rapid economic growth of China in recent decades has led to rapid urbanization in rural China. However, studies comparing the prevalence trends of different types of obesity and the association of obesity with hypertension between urban and rural areas in China are very scarce, and most studies have focused only on the difference in the prevalence of overweight and general obesity or hypertension among rural and urban populations. Therefore, the focus of this study was to examine the shifts in the overall distribution of the prevalence of different types of obesity and to estimate the risk of hypertension in different types of obesity among urban and rural adults aged 18-65 years. Seven iterations of the China Health and Nutrition Survey (CHNS), conducted in 1993, 1997, 2000, 2004, 2006, 2009 and 2011, were used in this study. A total of 53,636 participants aged 18-65 years were included. Obesity was classified into three types based on body mass index (BMI) and waist circumference (WC). A log-binomial model was constructed to estimate the prevalence ratio (PR) of hypertension with three types of obesity. The age-standardized prevalence of central obesity only, general obesity only, and both central and general obesity increased from 15.8, 0.2 and 2.9% in 1993 to 30.3, 0.9 and 10.3% in 2011, respectively. The prevalence of central obesity only (urban vs. rural: 20.8% vs. 13.4% in 1993, 29.6% vs. 30.6% in 2011) and both central and general obesity (urban vs. rural: 3.5% vs. 2.5% in 1993, 10.0% vs. 10.6% in 2011) in rural adults exceeded that in urban adults in 2011. Participants with both central and general obesity had the highest risk for incident hypertension compared with those with normal body measurements (adjusted PR, urban: 2.30 (95% CI, 2.01-2.63), rural: 2.50 (95% CI, 2.25-2.77)). Both WC and BMI should be considered measures of obesity and targeted in hypertension prevention. More attention should be paid to the incidence of central obesity in adults in rural China.

Sections du résumé

BACKGROUND BACKGROUND
China has the largest obese population in the world, and the prevalence of central obesity is increasing dramatically in China. Moreover, the rapid economic growth of China in recent decades has led to rapid urbanization in rural China. However, studies comparing the prevalence trends of different types of obesity and the association of obesity with hypertension between urban and rural areas in China are very scarce, and most studies have focused only on the difference in the prevalence of overweight and general obesity or hypertension among rural and urban populations. Therefore, the focus of this study was to examine the shifts in the overall distribution of the prevalence of different types of obesity and to estimate the risk of hypertension in different types of obesity among urban and rural adults aged 18-65 years.
METHODS METHODS
Seven iterations of the China Health and Nutrition Survey (CHNS), conducted in 1993, 1997, 2000, 2004, 2006, 2009 and 2011, were used in this study. A total of 53,636 participants aged 18-65 years were included. Obesity was classified into three types based on body mass index (BMI) and waist circumference (WC). A log-binomial model was constructed to estimate the prevalence ratio (PR) of hypertension with three types of obesity.
RESULTS RESULTS
The age-standardized prevalence of central obesity only, general obesity only, and both central and general obesity increased from 15.8, 0.2 and 2.9% in 1993 to 30.3, 0.9 and 10.3% in 2011, respectively. The prevalence of central obesity only (urban vs. rural: 20.8% vs. 13.4% in 1993, 29.6% vs. 30.6% in 2011) and both central and general obesity (urban vs. rural: 3.5% vs. 2.5% in 1993, 10.0% vs. 10.6% in 2011) in rural adults exceeded that in urban adults in 2011. Participants with both central and general obesity had the highest risk for incident hypertension compared with those with normal body measurements (adjusted PR, urban: 2.30 (95% CI, 2.01-2.63), rural: 2.50 (95% CI, 2.25-2.77)).
CONCLUSIONS CONCLUSIONS
Both WC and BMI should be considered measures of obesity and targeted in hypertension prevention. More attention should be paid to the incidence of central obesity in adults in rural China.

Identifiants

pubmed: 31146734
doi: 10.1186/s12889-019-7018-4
pii: 10.1186/s12889-019-7018-4
pmc: PMC6543650
doi:

Types de publication

Journal Article

Langues

eng

Pagination

661

Subventions

Organisme : NICHD NIH HHS
ID : R01 HD030880
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK104371
Pays : United States
Organisme : FIC NIH HHS
ID : D43 TW009077
Pays : United States
Organisme : NICHD NIH HHS
ID : P2C HD050924
Pays : United States

Références

Lancet. 2004 Jan 10;363(9403):157-63
pubmed: 14726171
BMC Public Health. 2013 Apr 10;13:327
pubmed: 23575244
Rev Esp Cardiol (Engl Ed). 2018 Mar;71(3):170-177
pubmed: 28789915
J Hypertens. 2015 May;33(5):948-56
pubmed: 25668349
J Epidemiol Glob Health. 2017 Mar;7(1):71-79
pubmed: 27940022
Clin Nutr. 2018 Aug;37(4):1259-1263
pubmed: 28583324
Prev Med. 2014 May;62:113-8
pubmed: 24552844
Int J Epidemiol. 2013 Jun;42(3):828-37
pubmed: 23771721
Econ Hum Biol. 2009 Jul;7(2):200-16
pubmed: 19560989
Int J Environ Res Public Health. 2016 Feb 25;13(3):
pubmed: 26927144
Circulation. 2008 Dec 16;118(25):2679-86
pubmed: 19106390
Int J Epidemiol. 2010 Dec;39(6):1435-40
pubmed: 19887509
Int J Epidemiol. 2015 Aug;44(4):1305-19
pubmed: 25747585
Stroke. 2009 Apr;40(4):1098-104
pubmed: 19211490
Int J Obes (Lond). 2007 Feb;31(2):272-8
pubmed: 16788569
Lancet. 2011 Feb 12;377(9765):557-67
pubmed: 21295846
Sci Bull (Beijing). 2017 Jan 30;62(2):92-98
pubmed: 36659489
Lancet. 2005 Sep 24-30;366(9491):1059-62
pubmed: 16182882
Obes Rev. 2012 Mar;13(3):287-96
pubmed: 22034908
Prev Med. 2010 Dec;51(6):460-5
pubmed: 20955726
Lancet. 2015 Dec 5;386(10010):2287-323
pubmed: 26364544
Int J Cardiol. 2017 Jan 15;227:516-523
pubmed: 27856040
Int J Cardiol. 2017 Jul 1;238:117-122
pubmed: 28318660
JAMA. 2003 May 21;289(19):2560-72
pubmed: 12748199
Int J Obes (Lond). 2007 Jan;31(1):177-88
pubmed: 16652128
Asia Pac J Clin Nutr. 2015;24(4):692-700
pubmed: 26693755
Hypertension. 1982 Sep-Oct;4(5):692-6
pubmed: 7106936
Int J Obes Relat Metab Disord. 1999 Aug;23(8):801-9
pubmed: 10490780

Auteurs

Chi Shen (C)

School of Public Policy and Administration, Xi'an Jiaotong University, No.28 Xianning West Road, Xi'an, 710049, Shaanxi, China.

Zhongliang Zhou (Z)

School of Public Policy and Administration, Xi'an Jiaotong University, No.28 Xianning West Road, Xi'an, 710049, Shaanxi, China. zzliang1981@163.com.

Sha Lai (S)

School of Public Policy and Administration, Xi'an Jiaotong University, No.28 Xianning West Road, Xi'an, 710049, Shaanxi, China.

Xingxing Tao (X)

Health Science Center, Xi'an Jiaotong University, No.76 Yanta West Road, Xi'an, 710061, China.

Dantong Zhao (D)

Health Science Center, Xi'an Jiaotong University, No.76 Yanta West Road, Xi'an, 710061, China.

Wanyue Dong (W)

Health Science Center, Xi'an Jiaotong University, No.76 Yanta West Road, Xi'an, 710061, China.

Dan Li (D)

School of Public Policy and Administration, Xi'an Jiaotong University, No.28 Xianning West Road, Xi'an, 710049, Shaanxi, China.

Xin Lan (X)

Health Science Center, Xi'an Jiaotong University, No.76 Yanta West Road, Xi'an, 710061, China.

Jianmin Gao (J)

School of Public Policy and Administration, Xi'an Jiaotong University, No.28 Xianning West Road, Xi'an, 710049, Shaanxi, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH